Quick answer: A radiopharmaceutical, or tracer, is a tiny amount of a radioactive atom attached to a molecule chosen because the body handles it in a specific way: sugar goes to active cells, a bone-seeking compound goes to areas of bone repair, and some molecules lock onto receptors on cancer cells. After the tracer is injected, swallowed or inhaled, a special camera detects the radiation it gives off and shows where it goes and how much builds up. That’s why nuclear medicine and PET show how organs work, not just how they look.
Two parts: the radioactive atom and the carrier
Most tracers have two pieces:
- The radioactive atom (radionuclide): gives off radiation that a camera can detect from outside the body.
- The carrier molecule: decides where the tracer goes, for example to bone, heart muscle, the thyroid or certain cancer cells.
Some tracers are just the radioactive atom, because the body already treats it in a useful way. Radioactive iodine, for example, goes straight to the thyroid.
The tracer principle
Tracers are given in amounts so small that they don’t change how your body works. They simply follow a normal process, such as using sugar, building bone or filtering blood, so doctors can watch that process. This is also why serious side effects are rare: the amount of drug is tiny compared with ordinary medicines.
Gamma cameras vs PET: two kinds of tracers
| Gamma (SPECT) tracers | Positron (PET) tracers | Therapy radiopharmaceuticals | |
|---|---|---|---|
| What they give off | Gamma rays | Positrons, which create paired gamma rays | Beta or alpha particles that damage nearby cells |
| Camera | Gamma camera, SPECT or SPECT/CT | PET/CT or PET/MRI | Often imaged afterward to check where it went |
| Common examples | Technetium-99m, iodine-123, thallium-201 | Fluorine-18, gallium-68, rubidium-82 | Iodine-131, lutetium-177, radium-223 |
| Typical uses | Bone, heart, thyroid, kidney, gallbladder, lung scans | Cancer, heart, brain scans | Thyroid disease and cancer, some prostate and neuroendocrine cancers |
Where tracers come from
Most tracers decay quickly, which keeps your radiation dose low but means they can’t be stockpiled.
- Generators: Technetium-99m, the most common tracer, is drawn each morning from a «generator» in which molybdenum-99 decays into it.
- Cyclotrons: Particle accelerators make PET tracers such as fluorine-18. Because F-18 loses half its radioactivity in under 2 hours, it’s often made nearby and delivered on the day.
- Nuclear reactors: produce several isotopes, including molybdenum-99 and iodine-131.
- Radiopharmacies: prepare each patient’s dose, check its quality and measure its radioactivity before it’s given.
This is why being on time for your appointment matters: your dose is ordered and prepared for a specific time.
Common tracers and what they show
| Tracer | Main use |
|---|---|
| Tc-99m MDP or HDP | Bone scans |
| Tc-99m sestamibi or tetrofosmin | Heart blood flow (nuclear stress test); parathyroid |
| Tc-99m mebrofenin | Gallbladder and bile flow (HIDA scan) |
| Tc-99m MAG3 or DTPA | Kidney function |
| Tc-99m MAA | Lung blood flow |
| Iodine-123 or Tc-99m pertechnetate | Thyroid scan |
| F-18 FDG | Sugar use: many cancers, infection, brain, heart |
| Ga-68 or F-18 PSMA tracers | Prostate cancer |
| Ga-68 DOTATATE | Neuroendocrine tumors |
| F-18 amyloid tracers | Alzheimer’s disease evaluation |
| Rb-82 or N-13 ammonia | Heart blood flow (PET) |
Theranostics: diagnose, then treat
«Theranostics» pairs a diagnostic tracer with a therapy that targets the same thing. For example:
- A PSMA PET scan shows whether prostate cancer cells carry the PSMA target; if they do, a lutetium-177 PSMA treatment can deliver radiation directly to those cells.
- A DOTATATE PET scan finds neuroendocrine tumors with certain receptors; lutetium-177 DOTATATE can then treat them.
This «see it, then treat it» approach is one of the fastest-growing areas of medicine.
Safety and side effects
- Radiation dose: Most diagnostic scans give doses similar to or lower than a CT scan. A whole-body PET/CT is higher, because it combines a tracer and a CT.
- Side effects: Allergic reactions and other side effects are rare.
- Leaving your body: Tracers lose radioactivity over time and leave mainly through urine. Drinking fluids and emptying your bladder often help.
- Precautions: After some tests, you may be asked to limit close contact with babies or pregnant people for a short time, or to pause breastfeeding. Therapies come with more detailed instructions.
From the scanner room
[TU EXPERIENCIA: cómo llega y se prepara la dosis en tu servicio (generador, kits, dosis de PET de un ciclotrón externo), el control de calidad, cómo afecta un retraso del paciente, y qué te preguntan los pacientes sobre «lo radiactivo».]
FAQ
Are radiopharmaceuticals dangerous?
They use small amounts of radiation, similar to other imaging tests. Serious side effects are rare, and the benefit of the information usually far outweighs the small risk.
How long does a tracer stay in my body?
It depends on the tracer. Many diagnostic tracers lose most of their radioactivity within a day or so, and the body clears them, mainly in urine.
Is the tracer the same as contrast dye?
No. Contrast dye makes structures visible on CT or MRI. A tracer is radioactive and shows how organs work on nuclear medicine and PET scans.
Why do I have to wait after the injection?
The tracer needs time to travel to and collect in the organ being studied: minutes for some scans, an hour for PET and up to several hours for bone scans.
Will I set off airport radiation detectors?
Sometimes, for a short time after some tests. Ask for a letter if you’re traveling soon.
This article is for general information only and is not medical advice. Follow the specific instructions your nuclear medicine team gives you.
Sources
- SNMMI. Fact sheets: What is nuclear medicine? What are radiopharmaceuticals?
- RadiologyInfo.org (ACR/RSNA). General Nuclear Medicine; PET/CT.
- FDA. Approved radiopharmaceuticals and theranostic agents.
- U.S. NRC. Medical uses of radioactive materials.